Vyome (NASDAQ:HIND) had its "sell (e-)" rating reaffirmed by analysts at
Weiss Ratings.
Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program [Yahoo! Finance]
Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program
Vyome (NASDAQ:HIND) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.
Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing [Yahoo! Finance]